Matregenix, a BioFutures company, wins the TechConnect Medical Innovation Challenge

Matregenix, a BioFutures company, won the TechConnect Medical Innovation Challenge, the world's largest medical device innovation competition held this week in Washington, D.C. The award comes with $25k cash prize and access to consortia that represent $20B in defense contracting authority. This award is sponsored by ATI | Advanced Technology International, Medical Technology Enterprise Consortium, Countering Weapons of Mass Destruction Consortium, and SHIC | Senior Healthcare Innovation Consortium in honor of innovation with the potential to help solve our nation's most critical medical and health tech challenges. Congratulations, Matregenix!